Literature DB >> 12883073

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas.

J Marrugat1, R D'Agostino, L Sullivan, R Elosua, P Wilson, J Ordovas, P Solanas, F Cordón, R Ramos, J Sala, R Masiá, W B Kannel.   

Abstract

AIM: To determine whether the Framingham function accurately predicts the 10 year risk of coronary disease and to adapt this predictive method to the characteristics of a Spanish population. METHOD AND
RESULTS: A Framingham function for predicting 10 year coronary deaths and non-fatal myocardial infarction was applied to the population of the province of Gerona, Spain, where the cumulated incidence rate of myocardial infarction has been determined since 1988 by a specific registry. The prevalence of cardiovascular risk factors in this region of Spain was established in 1995 by a cross sectional study on a representative sample of 1748 people. The number of cases estimated by the Framingham function for 10 year coronary deaths and non-fatal myocardial infarction was compared with that observed. The Framingham function estimated 2425 coronary heart disease cases in women and 1181 were observed. In men, 9919 were estimated and 3706 were observed. Recalibrating the Framingham equations to the event rate and the prevalence of the risk factors in Gerona led to estimates very close to the number of cases observed in Gerona men and women.
CONCLUSIONS: The Framingham function estimates more than doubled the actual risk of coronary disease observed in north east Spain. After calibration, the Framingham function became an effective method of estimating the risk in this region with low coronary heart disease incidence.

Entities:  

Mesh:

Year:  2003        PMID: 12883073      PMCID: PMC1732543          DOI: 10.1136/jech.57.8.634

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  20 in total

1.  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors:  E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal:  BMJ       Date:  2000-03-11

2.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

3.  Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.

Authors:  A Menotti; P E Puddu; M Lanti
Journal:  Eur Heart J       Date:  2000-03       Impact factor: 29.983

4.  [Cholesterol and tobacco: classics that withstand the passing of time].

Authors:  J M Ordovas
Journal:  Rev Esp Cardiol       Date:  2001-10       Impact factor: 4.753

5.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

6.  High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

Authors:  R Masiá; A Pena; J Marrugat; J Sala; J Vila; M Pavesi; M Covas; C Aubó; R Elosua
Journal:  J Epidemiol Community Health       Date:  1998-11       Impact factor: 3.710

7.  Long-term epidemiologic prediction of coronary disease. The Framingham experience.

Authors:  W B Kannel; M Larson
Journal:  Cardiology       Date:  1993       Impact factor: 1.869

8.  Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox.

Authors:  S M Artaud-Wild; S L Connor; G Sexton; W E Connor
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

9.  Silent myocardial ischemia and infarction: insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Cardiol Clin       Date:  1986-11       Impact factor: 2.213

10.  Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators.

Authors:  G Pérez; A Pena; J Sala; P Roset; R Masiá; J Marrugat
Journal:  Int J Epidemiol       Date:  1998-08       Impact factor: 7.196

View more
  68 in total

1.  Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Authors:  Renate B Schnabel; Thor Aspelund; Guo Li; Lisa M Sullivan; Astrid Suchy-Dicey; Tamara B Harris; Michael J Pencina; Ralph B D'Agostino; Daniel Levy; William B Kannel; Thomas J Wang; Richard A Kronmal; Philip A Wolf; Gregory L Burke; Lenore J Launer; Ramachandran S Vasan; Bruce M Psaty; Emelia J Benjamin; Vilmundur Gudnason; Susan R Heckbert
Journal:  Arch Intern Med       Date:  2010-11-22

2.  Risk factor scoring for coronary heart disease.

Authors:  Hans-Werner Hense
Journal:  BMJ       Date:  2003-11-29

3.  Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.

Authors:  John R Cook; Don Yin; Evo Alemao; Glenn Davies; Karl J Krobot; Enrico Veltri; Leslie Lipka; Xavier Badia
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Natalio Díaz Herrera; Gerardo Fernández Ochoa; Juan Ignacio Calvo Hueros; Francisco Buitrago
Journal:  Scand J Prim Health Care       Date:  2010-09-27       Impact factor: 2.581

5.  Can non-physician health-care workers assess and manage cardiovascular risk in primary care?

Authors:  Dele O Abegunde; Bakuti Shengelia; Anne Luyten; Alexandra Cameron; Francesca Celletti; Sania Nishtar; Vasu Pandurangi; Shanthi Mendis
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

Review 6.  Cardiovascular risk after bariatric surgery for obesity.

Authors:  John A Batsis; Michael G Sarr; Maria L Collazo-Clavell; Randal J Thomas; Abel Romero-Corral; Virend K Somers; Francisco Lopez-Jimenez
Journal:  Am J Cardiol       Date:  2008-07-17       Impact factor: 2.778

7.  Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.

Authors:  Francisco Buitrago; Juan Ignacio Calvo-Hueros; Lourdes Cañón-Barroso; Gerónimo Pozuelos-Estrada; Luis Molina-Martínez; Manuel Espigares-Arroyo; Juan Antonio Galán-González; Francisco J Lillo-Bravo
Journal:  Ann Fam Med       Date:  2011 Sep-Oct       Impact factor: 5.166

Review 8.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

Review 9.  Cardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population.

Authors:  John A Batsis; Francisco Lopez-Jimenez
Journal:  BMC Med       Date:  2010-05-25       Impact factor: 8.775

10.  High prevalence of subclinical atherosclerosis by carotid ultrasound among Mexican Americans: discordance with 10-year risk assessment using the Framingham risk score.

Authors:  Susan T Laing; Beverly Smulevitz; Kristina P Vatcheva; Anne R Rentfro; David D McPherson; Susan P Fisher-Hoch; Joseph B McCormick
Journal:  Echocardiography       Date:  2012-07-02       Impact factor: 1.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.